C128H147N39O16S6 — CID 157485019
1-[(1-methylimidazol-2-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;1-[(3-methylimidazol-4-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;(2R)-2-[[4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidin-1-yl]methyl]morpholine;2-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-yl]propan-2-ol;N-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]acetamide;[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]methanol (PubChem CID 157485019) has the molecular formula C128H147N39O16S6 and a molecular weight of 2680.24 g/mol. Its IUPAC name is 1-[(1-methylimidazol-2-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;1-[(3-methylimidazol-4-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;(2R)-2-[[4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidin-1-yl]methyl]morpholine;2-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-yl]propan-2-ol;N-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]acetamide;[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]methanol.
| Compound Name | 1-[(1-methylimidazol-2-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;1-[(3-methylimidazol-4-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;(2R)-2-[[4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidin-1-yl]methyl]morpholine;2-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-yl]propan-2-ol;N-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]acetamide;[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]methanol |
|---|---|
| PubChem CID | 157485019 |
| Molecular Formula | C128H147N39O16S6 |
| Molecular Weight | 2680.24 g/mol |
| Exact Mass | 2678.02 |
| IUPAC Name | 1-[(1-methylimidazol-2-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;1-[(3-methylimidazol-4-yl)methyl]-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidine;(2R)-2-[[4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]phenyl]piperidin-1-yl]methyl]morpholine;2-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]azetidin-3-yl]propan-2-ol;N-[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]acetamide;[1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-yl]methanol |
| SMILES | CC(=O)NC1CCN(c2ccc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)cn2)C1.CC(C)(O)C1CN(c2ccc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)cn2)C1.CS(=O)(=O)c1cccc(-c2ccc(C3CCN(C[C@H]4CNCCO4)CC3)cc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CCC(CO)C3)nc2)c1-c1nn[nH]n1.Cn1ccnc1CN1CCC(c2ccc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)cc2)CC1.Cn1cncc1CN1CCC(c2ccc(-c3cccc(S(C)(=O)=O)c3-c3nn[nH]n3)cc2)CC1 |
| InChI | InChI=1S/2C24H27N7O2S.C24H30N6O3S.C19H21N7O3S.C19H22N6O3S.C18H20N6O3S/c1-30-15-12-25-22(30)16-31-13-10-18(11-14-31)17-6-8-19(9-7-17)20-4-3-5-21(34(2,32)33)23(20)24-26-28-29-27-24;1-30-16-25-14-20(30)15-31-12-10-18(11-13-31)17-6-8-19(9-7-17)21-4-3-5-22(34(2,32)33)23(21)24-26-28-29-27-24;1-34(31,32)22-4-2-3-21(23(22)24-26-28-29-27-24)19-7-5-17(6-8-19)18-9-12-30(13-10-18)16-20-15-25-11-14-33-20;1-12(27)21-14-8-9-26(11-14)17-7-6-13(10-20-17)15-4-3-5-16(30(2,28)29)18(15)19-22-24-25-23-19;1-19(2,26)13-10-25(11-13)16-8-7-12(9-20-16)14-5-4-6-15(29(3,27)28)17(14)18-21-23-24-22-18;1-28(26,27)15-4-2-3-14(17(15)18-20-22-23-21-18)13-5-6-16(19-9-13)24-8-7-12(10-24)11-25/h3-9,12,15,18H,10-11,13-14,16H2,1-2H3,(H,26,27,28,29);3-9,14,16,18H,10-13,15H2,1-2H3,(H,26,27,28,29);2-8,18,20,25H,9-16H2,1H3,(H,26,27,28,29);3-7,10,14H,8-9,11H2,1-2H3,(H,21,27)(H,22,23,24,25);4-9,13,26H,10-11H2,1-3H3,(H,21,22,23,24);2-6,9,12,25H,7-8,10-11H2,1H3,(H,20,21,22,23)/t;;20-;;;/m..1.../s1 |
| InChIKey | BWPMBKOCLOSSRC-HRKAIKAZSA-N |
| XLogP | 11.94 |
| TPSA | 716.17 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 48 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 189 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2680.24 |
| LogP ≤ 5 | 11.94 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 48 |